AXIM BIOTECHNOLOGIES, INC. Quarterly Common Stock, Shares, Outstanding from Q4 2010 to Q2 2024

Taxonomy & unit
us-gaap: shares
Description
Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.
Summary
Axim Biotechnologies, Inc. quarterly Common Stock, Shares, Outstanding history and growth rate from Q4 2010 to Q2 2024.
  • Axim Biotechnologies, Inc. Common Stock, Shares, Outstanding for the quarter ending June 30, 2024 was 294M shares, a 29.3% increase year-over-year.
Common Stock, Shares, Outstanding, Quarterly (shares)
Common Stock, Shares, Outstanding, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2024 294M +66.8M +29.3% Jun 30, 2024 10-Q 2024-08-19
Q1 2024 278M +54.8M +24.5% Mar 31, 2024 10-Q/A 2024-05-22
Q4 2023 246M +53.5M +27.8% Dec 31, 2023 10-Q 2024-08-19
Q3 2023 238M +99.5M +72.1% Sep 30, 2023 10-Q 2023-11-20
Q2 2023 228M +89.5M +64.8% Jun 30, 2023 10-Q 2023-08-21
Q1 2023 224M +72.1M +47.6% Mar 31, 2023 10-Q 2023-05-22
Q4 2022 192M +54.3M +39.4% Dec 31, 2022 10-K 2024-04-16
Q3 2022 138M +2.21M +1.63% Sep 30, 2022 10-Q/A 2022-11-15
Q2 2022 138M +5.08M +3.82% Jun 30, 2022 10-Q 2022-08-16
Q1 2022 152M +24M +18.8% Mar 31, 2022 10-Q 2022-05-23
Q4 2021 138M +12.8M +10.2% Dec 31, 2021 10-K 2023-04-17
Q3 2021 136M +10.7M +8.54% Sep 30, 2021 10-Q 2021-11-22
Q2 2021 133M +19.9M +17.6% Jun 30, 2021 10-Q 2021-08-23
Q1 2021 128M +4.22M +3.42% Mar 31, 2021 10-Q/A 2021-06-02
Q4 2020 125M +60.5M +93.2% Dec 31, 2020 10-K/A 2022-04-19
Q3 2020 125M +62.4M +99.4% Sep 30, 2020 10-Q/A 2020-11-27
Q2 2020 113M +51.3M +83% Jun 30, 2020 10-Q/A 2020-08-18
Q1 2020 123M +62.2M +102% Mar 31, 2020 10-Q/A 2020-07-02
Q4 2019 64.9M +5.27M +8.85% Dec 31, 2019 10-K/A 2021-04-26
Q3 2019 62.8M +4.12M +7.02% Sep 30, 2019 10-Q 2019-11-14
Q2 2019 61.8M +4.3M +7.47% Jun 30, 2019 10-Q 2019-08-14
Q1 2019 61.1M +4.41M +7.78% Mar 31, 2019 10-Q 2019-05-15
Q4 2018 59.6M +5.02M +9.2% Dec 31, 2018 10-K/A 2020-05-20
Q3 2018 58.7M +4.1M +7.52% Sep 30, 2018 10-Q 2018-11-14
Q2 2018 57.5M +4.97M +9.46% Jun 30, 2018 10-Q/A 2018-08-17
Q1 2018 56.7M +4.1M +7.8% Mar 31, 2018 10-Q/A 2018-05-18
Q4 2017 54.6M +2.06M +3.92% Dec 31, 2017 10-K 2019-04-08
Q3 2017 54.6M +3.07M +5.97% Sep 30, 2017 10-Q 2017-11-20
Q2 2017 52.6M +10.8M +25.8% Jun 30, 2017 10-Q/A 2017-09-14
Q1 2017 52.6M +12.8M +32.2% Mar 31, 2017 10-Q/A 2017-09-14
Q4 2016 52.5M +12.9M +32.5% Dec 31, 2016 10-K 2018-03-15
Q3 2016 51.5M +12.1M +30.8% Sep 30, 2016 10-Q/A 2016-11-30
Q2 2016 41.8M +2.46M +6.25% Jun 30, 2016 10-Q/A 2016-08-25
Q1 2016 39.8M +6.74M +20.4% Mar 31, 2016 10-Q/A 2016-05-26
Q4 2015 39.6M +6.63M +20.1% Dec 31, 2015 10-K/A 2017-09-14
Q3 2015 39.4M +6.36M +19.3% Sep 30, 2015 10-Q 2015-11-23
Q2 2015 39.3M +6.34M +19.2% Jun 30, 2015 10-Q/A 2015-08-27
Q1 2015 33M +18K +0.06% Mar 31, 2015 10-Q 2015-05-13
Q4 2014 33M 0 0% Dec 31, 2014 10-K/A 2016-04-18
Q3 2014 33M 0 0% Sep 30, 2014 10-Q 2014-11-14
Q2 2014 33M 0 0% Jun 30, 2014 10-Q/A 2014-08-26
Q1 2014 33M 0 0% Mar 31, 2014 10-Q/A 2014-06-18
Q4 2013 33M 0 0% Dec 31, 2013 10-K 2015-04-14
Q3 2013 33M 0 0% Sep 30, 2013 10-Q 2013-11-18
Q2 2013 33M 0 0% Jun 30, 2013 10-Q 2013-08-14
Q1 2013 33M 0 0% Mar 31, 2013 10-Q 2013-05-15
Q4 2012 33M 0 0% Dec 31, 2012 10-K 2014-03-04
Q3 2012 33M 0 0% Sep 30, 2012 10-Q 2012-11-19
Q2 2012 33M Jun 30, 2012 10-Q 2012-08-14
Q1 2012 33M Mar 31, 2012 10-Q 2012-05-17
Q4 2011 33M +13M +65% Dec 31, 2011 10-K 2013-04-15
Q3 2011 33M Sep 30, 2011 10-Q/A 2011-11-21
Q4 2010 20M Dec 31, 2010 10-K/A 2012-05-01
* An asterisk sign (*) next to the value indicates that the value is likely invalid.